TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: MFR against B/Victoria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Use of celebrex
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of severe toxicity during preoperative chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Relative dose intensities (RDIs) for chemotherapeutic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cobb's angle change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Montreal Cognitive Assessment (MoCA) scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: low-back pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: return to work time
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvement in liver fibrosis scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Improvement in metabolic indices (TG‐I, TYG‐I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean peak consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of gingival bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of persisting diseased sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month event-free survival (EFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Sequential Clinical Assessment of Respiratory Function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: days of dysmenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total doses of oral painkiller
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolvaptan exposure on treatment Day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: clinically acceptable measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIHSS score in patients with mild stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in word-finding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental quality-adjusted life-year gain
Endpoint domain: Resource use
Primary endpoint: mean hyperopic shift of TCRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posterior corneal curvature steepening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle power during muscle contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sit-to-stand test performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: climbing stairs test performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage of weekly opioid negative UDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: engagement at week 12
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mitigation of cardiotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvement in nasolabial esthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mandibular length and position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of newly developed malignant formations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PF (Physical Functioning)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postprandial insulin response (iAUC0‐120)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: safety and efficacy of the combination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in inflammatory lesions (IL count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: GEA score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: AFAST score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Absolute Errors (AE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variable Errors (VE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibrosis regression rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned re-hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: voice-related distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: oral health beliefs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral health knowledge and behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parental oral health status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VPI (Vermillion Plaque Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment targets met
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Attrition levels low
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Positive views on person-centred approach
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: plaque accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: gingivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: plaque microbial counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: treatment attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: treatment completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: improvement in nasal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trial completion time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NDEV levels of Aβ 42
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NDEV total tau
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of RCTs published
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Disparities in RCTs related to socioeconomic development
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: muscle elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: concerns about risk compensation
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5-year cumulative incidence of locoregional recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in severity scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder passive ROM values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spontaneous and movement‐related pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extubation within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PV narrowing/stenosis incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: PV ostial diameter change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Serum GDF15 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed memory improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Preference for PAC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GRC scale scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction of VEGF, iNOS and IDO expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Salivary alpha amylase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Pain and Disability Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beliefs about imaging for LBP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin moisturizing effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Amount of dessert consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary Albumin Creatinine (UAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: percentage of Swahili-English word-associations recalled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tandem walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical specificity for Cushing's syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical sensitivity for Cushing's syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure freedom for at least 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Seizure freedom for up to 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: best corrected visual acuity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DME development rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVR injection requirement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean score of echinococcosis control knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of identification of expired medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QoR15 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: C-Reactive Protein (CRP) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post-ESD bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: NRS (Numerical Rating Scale) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot strike angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stiffness of lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Median attendance rate for remote sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: AK-clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in solar elastosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increase in collagen type I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Completion of advance care planning activities
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: safety of sodium reduction strategies
Endpoint domain: Adverse events/effects
Primary endpoint: Activation of reward-related caudate to food cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Activation of reward-related insula to food cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Activation of cognitive control-related dorsolateral prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Atrial nitroso-redox balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative atrial effective refractory period (AERP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health-related quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: time to first clinically significant exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PONV severity score at postoperative 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total volume of fluid administered intraoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: narcotic intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient outcomes
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Consistent ovulation inhibition (progesterone < 3 ng/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Progesterone-receptor-modulator-associated endometrial changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systolic blood pressure decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of intradialytic hypotension (IDH)
Endpoint domain: Adverse events/effects
Primary endpoint: vasodilator responses at the onset of exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vasodilator responses during steady-state submaximal exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: kinetics of vasodilation preceding steady-state responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of esophageal injury (EI) post ablation
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from atrial tachyarrhythmias
Endpoint domain: Physiological/clinical
Primary endpoint: DMFT incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMFS incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PUFA incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grams of urine loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Current tobacco use and its association with OUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRT time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall risk proportions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood ATP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ratio of βATP to inorganic phosphate in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: prognostic risk score
Endpoint domain: Mortality/survival
Primary endpoint: Stigma related to dementia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in reading acquisition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Blood loss at 2 h after delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood loss at 6 h after delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood loss at 24 h after delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: physical recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Minimum axial area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median seizure frequency percent reduction from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Definite-plus-probable SUDEP rate
Endpoint domain: Mortality/survival
Primary endpoint: Primary efficacy endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean weighted MOAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with moderate-to-severe functional limitation (PCFS grade 3-or-4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with no functional limitations (PCFS grade 0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PHQ-2 score ≥ 3
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Standard Deviation of Normal Sinus Beat Intervals (SDNN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean change in rTNSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: μ‐TBS to dentine of primary teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of abdominal fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean number of words spoken by the child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative sepsis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Sepsis-related death
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative need for epinephrine and norepinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change scores of MAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change scores of Fugl‐Meyer Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change scores of Barthel Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported sleep problems
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: immunoglobulin antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ALP reduction from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALP normalization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychological QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 0.4 logarithm of the minimum angle of resolution (20/50) or better visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 logarithm of the minimum angle of resolution (20/200) or better visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of secretory immunoglobulin A and lactoferrin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total cost of admission
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: average volume decrease in the legs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subcutaneous tissue thickness decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ankle range of motion (ROM) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Post-operative pain intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of mismatch negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Working memory-related theta oscillations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cervical Joint Position Sense (CJPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craniocervical flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary stability of the reattached tuberosities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rotational movements of tuberosities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest expansion at the level of the axilla
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to prone positioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Orthodontic pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OHRQoL (OHIP-14 scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life